Teva to buy 57 percent of Taiyo for $460 million

The deal gives Taiyo an enterprise value of $1.3 billion and is expected to be accretive to GAAP earnings within four quarters after closing, Teva (TEVA.TA Taiyo is the third largest generic pharmaceutical company in Japan with sales of $530 million in...